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Abstract
Analyzing data obtained from genome-wide gene expression experiments is challenging due to the quantity of variables,
the need for multivariate analyses, and the demands of managing large amounts of data. Here we present the R package
pcaGoPromoter, which facilitates the interpretation of genome-wide expression data and overcomes the aforementioned
problems. In the first step, principal component analysis (PCA) is applied to survey any differences between experiments
and possible groupings. The next step is the interpretation of the principal components with respect to both biological
function and regulation by predicted transcription factor binding sites. The robustness of the results is evaluated using
cross-validation, and illustrative plots of PCA scores and gene ontology terms are available. pcaGoPromoter works with any
platform that uses gene symbols or Entrez IDs as probe identifiers. In addition, support for several popular Affymetrix
GeneChip platforms is provided. To illustrate the features of the pcaGoPromoter package a serum stimulation experiment
was performed and the genome-wide gene expression in the resulting samples was profiled using the Affymetrix Human
Genome U133 Plus 2.0 chip. Array data were analyzed using pcaGoPromoter package tools, resulting in a clear separation of
the experiments into three groups: controls, serum only and serum with inhibitor. Functional annotation of the axes in the
PCA score plot showed the expected serum-promoted biological processes, e.g., cell cycle progression and the predicted
involvement of expected transcription factors, including E2F. In addition, unexpected results, e.g., cholesterol synthesis in
serum-depleted cells and NF-kB activation in inhibitor treated cells, were noted. In summary, the pcaGoPromoter R package
provides a collection of tools for analyzing gene expression data. These tools give an overview of the input data via PCA,
functional interpretation by gene ontology terms (biological processes), and an indication of the involvement of possible
transcription factors.
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Introduction
Working with genome-wide gene expression data is challenging
for the typical molecular biologist with training mainly focusing on
laboratory techniques and only to lesser extend in the fields of
mathematics or biostatistics. The large number of gene expression
measurements available requires a meaningful reduction of the
data set to make its results comprehensible. Data typically
originate from DNA microarray hybridization experiments or,
more recently, from next-generation sequencing experiments. An
example of an experiment requiring genome-wide gene expression
analysis is the extraction of RNA from a tissue sample taken in situ
or from an ex vivo cultured cell line. The differences in mRNA
levels between the different samples can be ascribed to three
different effects: consequences of cellular signal transduction,
cellular differentiation or the migration of cells into or out of the
tissue. Under these circumstances, key transcription factors are
responsible for establishing differences in the mRNA levels.
Moreover, the transcription factors involved can often be linked
to specific biological processes. For instance, the transcription
factor NF-kb is linked to inflammation [1], whereas the
transcription factor HNF-4a is linked to lipid metabolism [2].
Therefore, data analysis of genome-wide gene expression data
should allow for the interpretation of differences between groups of
experiments in terms of transcription factor involvement and
functional biological terms.
Several data analysis strategies for genome-wide gene expression
data combine an unsupervised approach for reducing the
dimension of the dataset with a supervised approach for drawing
conclusions (for reviews see [3,4,5]). Along with the advent of
DNA-microarray technology, cluster analysis has become a
popular accompaniment of unsupervised investigations of high-
dimensional data. Commonly used cluster analysis methods
display gene expression data using heat maps and dendrograms
[6,7,8]. Principal component analysis (PCA) and the related
correspondence analysis (CA) represents another class of explor-
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dimension reduction, and even though the method was first
introduced into chemistry and biology in the late 1970’s (for
review see [9]), it was already described in the early twenties
century [10]. The usefulness of PCA for analysis of genome-wide
gene expression data has recently been reviewed [11]. However,
whereas clusters of microarray hybridization experiments are
typically easily distinguishable in standard PCA plots with few
dimensions, the axes are not easily interpretable. We have
previously demonstrated that PCA can provide an experiment-
oriented view in combination with a functional interpretation of
the PCA axes with respect to transcription factor involvement and
biological function [12,13,14]. Although it is currently possible to
link PCA with annotation analysis and overrepresentation analysis
of predicted transcription factor binding sites, no software package
available is designed to streamline this analysis strategy. It is
necessary to use several software packages and to reformat the
data between the different packages. Moreover, the bioconductor
repository [15] holds at present 516 R packages, but none of these
packages implement a transcription factor binding site overrepre-
sentation analysis algorithm. Some of the bioconductor packages
implement PCA (e.g. MADE4 [16] and pcaMethods [17]) and
others annotation analysis (e.g. GOseq [18] and GOstats [19]), but
these packages are not designed to work together. It was therefore
the purpose of the present work to develop a single R package with
a number of wrapper functions that would easily combine PCA
with annotation analysis and transcription factor binding site
overrepresentation analysis. Thus, the coupling of the intuitive
understanding of differences between groups of experiments, the
potential involvement of transcription factors and biological
processes is automated by the pcaGoPromoter package. Com-
pared with other commercial and open source pathway analysis
software [20], the pcaGoPromoter is unique in using PCA score
plot interpretations.
Currently, the package provides fast and straightforward data
analysis for any genome-wide gene expression data platform using
gene symbols or Entrez IDs as probe identifiers. In addition,
several Affymetrix GeneChip platforms are also supported. In this
work, we describe a serum stimulation experiment using human
monocytes that was specifically designed to illustrate the use of the
pcaGoPromoter package algorithms and tools.
Materials and Methods
Program description
The pcaGoPromoter package provides functions that have been
designed for use with any gene expression analysis platform. In this
report, however, we use data derived from the Affymetrix
GeneChip platform for exemplification. The overall idea was to
achieve an interpretation of the score plot axes of a PCA (function
pca) in terms of biological processes (function GOtree) and the
transcription factors involved (function primo).
A pcaGopromoter online version providing access to the most
important plot functions is available at http://gastro.sund.ku.dk/
brew/pcaGoPromoter.html.
Data import
The pcaGoPromoter package supports Bioconductor’s Expres-
sionSet class [15], however, in addition any normalized data can
be used when formatted as a table with either Affymetrix probe set
IDs, gene symbols or Entrez IDs as row names and experiment
IDs as column identifiers. The serum stimulation data used as an
example in the present work originated from the Affymetrix
GeneChip platform, and the required pre-processing of the CEL
files was performed with the affy package [21]. A data object was
created with the ReadAffy function. Background correction and
normalization was performed using the rma function [22]. The
pca and GOtree functions work with any Affymetrix GeneChip,
which is supported by Affymetrix CDF files, whereas the primo
function comes with data files that support the most popular
human (HG-U133 plus 2.0 and Human Gene ST 1.0), mouse
(Mouse Genome 430 2.0 Array) and rat (Rat Genome 230 2.0
Array) GeneChip arrays. In addition the primoData function
allows custom data files for primo to be produced by the user.
Principal component analysis using the function pca
PCA is a well-established method for multivariate analyses
[9,23]. PCA reduces dimensionality by projecting experiments
(each hybridization experiment) into a new subspace with fewer
dimensions than the original space of the variables (in our case
probe set IDs). It is important to note that PCA also can be used
with the experiments as variables. pcaGoPromoter is, however,
only intended for use in a setting with probes as variables. Each
hybridization experiment yielded a vector of p expression levels Xi
referring to p probe set IDs on the chip. The data from n
hybridization experiments were used to compute k~ð1,...,KÞ
principal components:
PC(k)~b1k|X1 z ... zbpk|Xp
where b(k)~(b1k,...,bpk) is a loading vector which satisfies the
constraint
P p
j~1
b2
ij~1. The first principal component PC(1)
explains most of the variance of the data, the second principal
component PC(2) second most, and so forth.
The loading bpk quantifies the importance of the p9
th probe set
ID on the chip for the k9
th dimension of the reduced predictor
space. The sign and magnitude of the loadings were used to find
important probe set IDs for functional interpretation.
In pcaGoPromoter, the function pca calculates the principal
components of a data matrix with hybridization experiments in
columns and probe set IDs in rows, by internally calling the
function prcomp of the R base package ‘stats’. It should be noted
that pca uses the transformed input matrix for calculations, as the
convention for PCA is that experiment are in rows and variables in
columns. The function getRankedProbeIds works on pca
objects and is used to select the most important positive and
negative probe set IDs based on their loadings. Going forward, we
use a selection of the 2.5% probes set IDs with highest or lowest
loadings, respectively, as an example. In a separate section under
the Results and discussion section the selection of this parameter is
discussed.
Mapping principal component axes to enriched gene
ontology terms using the function GOtree
We were interested in joining a functional interpretation to the
directions of the axes for each principal component in the PCA
score plot. The Gene Ontology (GO) Consortium [24] provides a
set of databases that contain functional annotations for genes. The
pcaGoPromoter package associates GO terms with biological
processes for each principal component in both directions. This is
done by calculating the overrepresentation of the GO terms in the
annotation of genes with high absolute loadings for each principal
component. This calculation is performed using the function
GOtree, which operates either on the Affymetrix probe set IDs,
gene symbols, or Entrez IDs. In case the input is not of class
ExpressionSet, the input type is controlled with the argument
pcaGoPromoter - Biological Interpretations of PCA
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function GOtree are then visualized in a tree structure of
overrepresented GO terms along with their corresponding p-
values. The calculation for overrepresentation can be performed
using either Fisher’s exact test for proportions, or with an exact test
for the number of successes in a Bernoulli sequence (controlled
with the argument statisticalTest). The calculation details for
overrepresentation of annotation terms in gene lists have earlier
been published [25,26].
Mapping principal component axes to enriched
promoter cis-elements using the functions primoData and
primo
Transcription factors can be organized according to their DNA-
binding motifs. The TRANSFAC database [27] and the Jaspar
database [28] contain information about consensus DNA-binding
motifs for a wide variety of transcription factors. Information
about the binding sequences is organized in position weight
matrices.
The primoData function is used to generate a table with
information about potential transcription factor binding sites
discovered by searching promoters for matches to position weight
matrices. The function is based on a previously published
algorithm [29], which was implemented with some modifications
in C++ (as PRIMO: PRomoter Integration in Microarray result
Organization) [30] and in R for the pcaGoPromoter package in
the present work. Fig. 1 illustrates the search algorithm for
determining transcription factor binding sites using position weight
matrices. The threshold score is calculated for each position weight
matrix as the threshold that generates hits in a given percentage of
all the promoters with a default of 10%, which is suggested in the
original description of the algorithm [29]. When the highest
possible score for position weight matrix identify more binding
sites than 10% of all promoters, the highest possible threshold is
chosen. The selection of the threshold for reporting a hit is thus
based on the distribution of scores for a given position weight
matrix in the promoter set being used. Other strategies for
threshold selection based on e.g. a core motif [31] or motif
conservation across species [32] have also been described in the
literature. The primoData function is thus a tool for inclusion of
custom promoter sets in the analysis. It takes as inputs two
arguments (promoters, matrices). The promoters argument is a list
with two elements. The first element is a list of Refseq identifiers
and the second list element is a list of promoter sequences. The R
command
Promoters ,- pcaGoPromoters:::primoData.getPromo-
ter( filename )
loads promoter sequences from a file in FASTA format into the
promoters variable . The matrices argument is an R list of list
elements. Each list element contain 3 data elements (baseId, name
and pwm). baseId is a character vector with a base id, name is a
character vector with the common name for the matrix, pwm is a
position weight matrix with the base A,C,G,T in rows and the
weights in columns. The primoData function is, however, only
intended to be used by experts in bioinformatics because it
requires a certain level of bioinformatics skills to obtain and format
the input files from the public databases. In addition the function
requires much processor time. The output of primoData is a data
file to be used with the function primo, which is the function that
actually joins the promoter analysis to the PCA analysis.
The R command:
myPrimoData ,- primoData (promoters , fewMatrices)
calculates the myPrimoData object on custom promters and
pwm matrices and the R command:
TFs ,- primo( myLoadings , primoData = myPrimoData)
Calculates cis-element overrepresentation analysis on the set of
probe set IDs (myLoadings) using the custom data.
To ease the use of the pcaGoPromoter package precalculated
data files for promoters in the human, mouse and rat genomes are
available on the project home pages (bioconductor and google.-
code). For these genomes, binding sites have been identified for
promoter regions upstream of reference sequence mRNA
transcripts (Refseq) [33]. We have defined the promoter region
as 100 base pairs downstream and 1000 base pairs upstream of the
59 end of each Refseq mRNA transcript, for a total of 1100 base
pairs.
The input for primo is an object of class ExpressionSet.
Alternatively a vector with either Affymetrix probe set IDs, gene
symbols or Entrez IDs can be used in which case information
about the organism is required and entered as the ‘‘org’’
argument. An option allows for the selection of multiple test
correction using the argument p.adjust.method with the default
being the false discovery rate. The result is a list of possible
transcription factor binding sites that are either over- or
underrepresented.
Data – serum stimulation of a human monocyte cell line
To illustrate the use of pcaGoPromoter, including the rationale
behind the analysis strategy, an experiment was designed and
conducted. A serum-starved human monocyte cell line (ATCC
Number: CRL-9853) was stimulated by serum in the presence
(10 nM) or absence of the specific Erk-1/2 inhibitor, U0126 [34].
Twenty-two hours after serum addition, cells were harvested.
RNA was extracted, and gene expression was analyzed by
Affymetrix Human Genome U133 plus 2.0 arrays. Thirteen
experiments were performed: five control experiments (serum-
starved), three serum-stimulated, and five serum-stimulated in the
presence of the inhibitor U0126. The addition of serum and
inhibitor represented experimental manipulations, and these steps
should be reflected in the independent effects identifiable in the
principal components. Serum response is related to cell cycle
progression [35], which in turn is regulated by E2F transcription
factors [36]. Members of the Ets and Elk transcription factor
families are the immediate early downstream nuclear targets of
Erk-1/2 signaling [37], whereas activation of E2F transcription
factors is a later event. Thus, it was expected that three groups of
experiments would be discernible in the principal component
analysis. Cell cycle progression should be reflected in the gene
ontology analysis, and the Ets, ELK and E2F transcription factors
were predicted to be revealed in the PRIMO analysis. Therefore,
this experiment is well-suited to illustrate the functional interpre-
tation of principal component score plot axes using overrepresen-
tation analysis of annotation terms and predicted transcription
factor binding sites. Data from the serum stimulation experiment
are available at the gene expression omnibus under the accession
number GSE27071 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?token=nvydbmmukoikora&acc=GSE27071).
Results and Discussion
Functional interpretation of monocyte serum response
The Affymetrix CEL files were read into R using the affy
package followed by calculation of a normalized gene expression
measure for each probe set ID using rma.
library(affy)
chipdata ,- ReadAffy()
chipdataRMA ,- rma(chipdata)
Load the pcaGoPromoter package.
pcaGoPromoter - Biological Interpretations of PCA
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Do everything in one command (‘‘groups’’ annotate experi-
ments into classes in the plot. The variable is predefined to contain
the classes: ‘‘control’’, ‘‘serumInhib’’ and ‘‘serumOnly’’):
pcaInfoPlot(chipdataRMA, groups=groups)
The resulting score plot (Fig. 2) displays the first two principal
components. The experiments are colored according to the
grouping vector, and a shaded ellipse marks the 95% confidence
interval for the class. The experiments were grouped in clusters as
expected: top (control), bottom left (serum only) and bottom right
(serum with inhibitor). The three groups were separated along the
1
st principal component axis (x-axis), which explained 21% of the
variance. This axis illustrates the portion of the serum effect
influenced by the Erk-1/2 inhibitor. The control group was
separated from the others along the 2
nd principal component axis
(y-axis), which explained 16% of the variance. This axis illustrates
the portion of the serum effect that is independent of the Erk-1/2
inhibitor. The axes were annotated with the top overrepresented
GO terms and predicted transcription factor binding sites. The cell
cycle progression was reflected in the negative direction of the 1
st
principal component axis. Involvement of E2F and Ets transcrip-
tion factors was predicted, because binding sites in gene promoters
influence this direction of the axis.
The pcaInfoPlot function is designed to perform the key
calculations required for functional interpretations of the PCA.
The underlying calculations can be conducted individually with
possibilities for choosing additional options as explained in the
following.
Run PCA:
pcaObj ,- pca(chipdataRMA)
The probe set IDs on the GeneChip can now be ranked
according to their effect on the projection of the experiments into
the new subspace defined by the 1
st and 2
nd principal component.
The function getRankedProbeIds generates a ranked list of the
probe set IDs that mostly contribute for placing experiments
along the chosen principal component, here set by the argument
‘‘pc’’:
probesPC1neg ,- getRankedProbeIds(pcaObj, pc=1,
decreasing=FALSE)[1:1365]
The number of probe set IDs chosen (1365) constitutes 1365/
54613=2.5% of the total number of probe set IDs on the HG-
U133 Plus 2.0 array.
The probes associated with the negative direction of the first
principal component axis can now be interpreted in terms of
biological processes:
GOtreeObj ,- GOtree(probesPC1neg)
Figure 1. Description of the PRIMO algorithm. This figure shows the calculation of a position weight matrix (PWM) score for a specific DNA
sequence. The sequence window under calculation is shown at the bottom in capital letters. To the left is the PWM, which can be obtained from the
Transfac or Jaspar databases. A value for each position was calculated based on the PWM value for the specific base. Underflow and the trivial zero
result (if zero occurs in the PWM) were avoided as indicated.
doi:10.1371/journal.pone.0032394.g001
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more genes, the total number of genes found for the term and a p-
value calculated using an exact binominal test (binom.test(x, n, p)).
x: number of successes (number of probes in the extreme
loading list having the specified GO term)
n: number of experiments (the total number of probes having
the specified GO term)
p: the hypothesized probability of success (number of probes in
the extreme loading list/total number of genes used in expression
analysis)
Fisher’s exact test for proportions can be used (option:
significance Method=‘‘fisher’’)
Using the command plot(GOtreeObj) plots a tree view (Fig. 3)
of the relations between the GO terms.
Figure 2. Principal component analysis score plot using pcaInfoPlot(). This plot shows the output from the function pcaInfoPlot(). This
function makes a principal component analysis score plot and applies functional annotation to the axis. The plot shows the experiments of the three
experimental groups (control, serum only and serum with inhibitor) separated into three clusters. The 1
st principal component (PC1), which contained
21% of the variance, shows the differences in gene expression caused by the inhibitor and the serum. The serum-only group (serumOnly) is in the
most negative direction. The control group is in the middle. The serum with inhibitor (serumInhib) group is in the positive direction. The 2
nd principal
component (PC2), which contained 16% of the variance, shows the effect of the added serum. The control group is in the positive direction, and the
serum-supplemented groups (serumOnly and serumInhib) are in the negative direction. Each axis is functionally annotated with the five most
significant GO terms (biological processes) and the five most significant overrepresented predicted transcription factor binding sites.
doi:10.1371/journal.pone.0032394.g002
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two major branches in the GOtree of overrepresented biological
processes. One branch was related to the cell cycle, and the other
was related to RNA metabolism. The final leaf on the cell cycle
branch in the GO tree (Fig. 3) was the term ‘‘mitotic sister
chromatid segregation’’. Thus, the 2.5% of genes with the most
negative loadings in the 1
st principal component have an
overrepresentation of annotation terms related to progression in
the cell cycle. This was as expected for the ‘‘serum only’’
experiments, which were projected towards negative values of the
1
st principal component. Moreover, it can be hypothesized that
the ‘‘serum inhibitor’’ experiments were also inhibited in cell cycle
progression. This hypothesis requires experimental validation, e.g.,
DNA synthesis measurements using labeled nucleosides. It should
Figure 3. Negative direction PC1 gene ontology tree using 1365 probes. Significantly overrepresented gene ontology terms (biological
processes) in the negative direction of the 1
st principal component using 2.5% of the most important probes were used to draw a tree graph. The
gene ontology (GO) tree starts with the top term ‘biological process’ and then splits out into more specific terms. Box color indicates the p-value
range. Each box contains the name of the process, the GO term number, the p-value, the number of genes in the subset and the total number of
genes, which are annotated using this term. The GO tree splits into two major branches. The upper branch indicates cell division by mitosis, and the
lower branch indicates mRNA processing.
doi:10.1371/journal.pone.0032394.g003
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signs of the loadings following the PCA. The terms are thus purely
mathematical and have no biological meaning.
Interestingly, GO overrepresentation analyses of the positive
PC2 direction revealed overrepresentation of the term ‘‘cholesterol
biosynthetic process’’ (p=3.86610
25). The function GOtreeHits
found eight genes in the PC2 positive loadings annotated with this
term. The probes interrogate genes involved in cholesterol
synthesis (Table 1), a process that may be up-regulated in serum-
starved cells due to a lack of cholesterol to provide lipoproteins
(e.g., low-density lipoprotein; LDL) in the serum-free medium.
Strict feedback control of cellular cholesterol biosynthesis is well-
known [38], but changes in the expression patterns of genes
involved in cholesterol biosynthesis were unexpected in the present
serum stimulation experiment, which focused on the cell cycle and
MAP kinase activation. However, the literature does provide
support for serum starvation as an inducing stimulus for
cholesterol synthesis [39]. This demonstrates that functional
interpretation of score plot axes can yield useful insights into
cellular processes.
Overrepresented transcription factor binding sites in the
promoters of genes defined by the probe set IDs with the 2.5%
most extreme negative loadings for the 1
st principal component
were found using the function primo:
primoRes ,- primo(probesPC1neg)
The result ‘‘primoRes’’ contained two lists, overRepresented
and underRepresented. Each list holds the respective transcription
factor position weight matrix with p-values for over- and
underrepresentation calculation using Fisher’s exact test for
proportions. Table 2 shows position weight matrices with
overrepresentation hits in gene promoters (probe set IDs) with
extreme (2.5%) positive or negative loadings. The list of position
weight matrix hits for promoters associated with probe set IDs
with the most negative loadings has three matrices for E2F
transcription factors, whereas E2F position weight matrix hits were
not found in the promoters associated with the probe set IDs with
the most positive loadings in the 1
st principal component. This was
as expected because the probe set IDs with the most negative
loadings of the 1
st principal component represent cell cycle
progression with activated E2F responsive promoters. Position
weight matrix hits for the immediate downstream targets of MAP
kinase activation, Ets and Elk transcription factors, are overrep-
resented in both directions of the 1
st principal component. The
interpretation is that different Ets and Elk transcription factor
targets are activated by serum in the absence and presence of the
Erk-1/2 inhibitor.
The probe set IDs joined to promoter hits for position weight
matrices can be retrieved using the function primoHits as
follows:
probeIdsE2F ,-primoHits(probesPC1neg,id= ‘‘9262’’)
This function generates the list of probe set IDs associated with
promoter hits for the E2F position weight matrix with the Jasper
accession number MA0024 and ID 9252. A list of gene names can
be retrieved using the mget function from the AnnotationDBI
package and the hgu133plus2.db package:
geneNamesMA0024 ,- mget(probeidsE2F, ‘‘hgu133-
plus2GENENAME’’)
Among the resulting hits is proliferating cell nuclear antigen
(PCNA), which is a well-known component of the DNA replication
fork (for a review see [40]). Moreover, a functional E2F-binding
site has been demonstrated in its promoter [41].
Predicted binding sites for proteins of the NF-kB transcription
factor complex (c-REL (pwm MA0107) and NF-kB (pwm
MA0061)) were also overrepresented in the gene promoters (probe
set IDs) with extreme positive loadings for the 1
st principal
component. This correlated with the overrepresentation of the
GO term ‘‘regulation of I-kappaB kinase/NF-kappaB cascade’’ in
the same direction of the 1
st principal component (Fig. 2). The
interpretation is that the combined inhibitor and serum treatment
led to NF-kB activation in the monocyte cell line. This is another
example of an interesting result that is somewhat novel with
respect to NF-kB activation. However, NF-kB inhibition by Erk-
1/2 has been reported in endothelial cells [42] and again
demonstrates the ability of our method to find and interpret
biologically-relevant gene expression changes.
Relationship between loadings, variance and gene
expression patterns. The first two principal components of
the PCA (Fig. 2) explain 37% (21%+16%) of the variance in the
original data. The variance in gene expression data can be
interpreted in terms of gene expression patterns, which is a
convenient way of interpreting the variance in gene expression
analyses.
Fig. 4 shows the gene expression measurements of the three
probe set IDs with the most negative or positive loadings in the 1
st
and 2
nd principal component. The probe set IDs with the highest
positive loadings had expression patterns with the highest
expression levels in the serum + inhibitor group for the 1
st
principal component. The control group had an intermediate
expression level, and the serum only group had the lowest
expression level. For the probe set IDs with most influence on the
negative direction of the 1
st principal component, the reverse was
true. Likewise, probe set IDs with high or low expression in the
Table 1. Probe set IDs annotated with GO 6695: ‘‘cholesterol biosynthetic process’’.
Probe Set ID Gene Symbol Gene Title
201791_s_at DHCR7 7-dehydrocholesterol reductase
200862_at DHCR24 24-dehydrocholesterol reductase
203027_s_at MVD mevalonate (diphospho) decarboxylase
209279_s_at NSDHL NAD(P) dependent steroid dehydrogenase-like
202245_at LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
201275_at FDPS farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase,
geranyltranstransferase)
211113_s_at ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1
200642_at SOD1 superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
doi:10.1371/journal.pone.0032394.t001
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inhibitor) defined the positive or negative direction of the 2
nd
principal component.
Thus, almost 40% of the variance in the original data was
due to the four distinct gene expression patterns seen in
Fig. 4.
Table 2. Overrepresentation analysis for predicted transcription factor binding sites using Primo on the 1
st principal component.
PC1 negative direction
Matrix ID Length Name Raw p-value FDR
MA0098 6 ETS1 6,30E-16 6,17E-14
MA0080 6 SPI1 1,18E-13 1,16E-11
MA0062 10 GABPA 5,02E-09 4,92E-07
MA0024 8 E2F1 1,75E-05 1,72E-03
MA0028 10 ELK1 3,63E-05 3,56E-03
MA0076 9 ELK4 4,39E-04 4,30E-02
MA0075 5 Prrx2 6,74E-04 6,61E-02
MA0131 10 MIZF 3,43E-03 3,36E-01
MA0060 16 NFYA 4,19E-03 4,11E-01
PB0008 15 E2F2_1 4,19E-03 4,11E-01
PB0009 15 E2F3_1 1,96E-02 1,92E+00
PB0020 17 Gabpa_1 1,51E-01 1,48E+01
PB0027 17 Gmeb1_1 1,51E-01 1,48E+01
MA0004 6 Arnt 1,64E-01 1,60E+01
MA0104 6 Mycn 1,64E-01 1,60E+01
PB0095 16 Zfp161_1 6,05E-01 5,93E+01
PB0179 15 Sp100_2 1,02E+00 1,00E+02
MA0151 6 ARID3A 1,16E+00 1,14E+02
MA0006 6 Arnt::Ahr 1,49E+00 1,46E+02
MA0062 11 GABPA 1,74E+00 1,70E+02
PB0164 17 Smad3_2 6,08E+00 5,96E+02
MA0058 10 MAX 6,54E+00 6,41E+02
PB0108 14 Atf1_2 4,95E+01 4,85E+03
MA0259 8 HIF1A::ARNT 8,56E+01 8,39E+03
PC1 Positive
Matrix ID Length Name Raw p-value FDR
MA0098 6 ETS1 3,23E-18 5,36E-16
MA0080 6 SPI1 7,68E-14 1,27E-11
MA0062 11 GABPA 1,93E-13 3,21E-11
MA0028 10 ELK1 1,68E-07 2,79E-05
MA0076 9 ELK4 1,77E-07 2,93E-05
MA0062 10 GABPA 5,86E-07 9,73E-05
MA0162 11 Egr1 9,51E-07 1,58E-04
PB0020 17 Gabpa_1 3,35E-04 5,55E-02
MA0039 10 Klf4 5,11E-02 8,48E+00
MA0146 14 Zfx 4,96E-01 8,23E+01
MA0079 10 SP1 8,17E-01 1,36E+02
PB0039 16 Klf7_1 1,39E+00 2,31E+02
PB0011 15 Ehf_1 3,06E+00 5,09E+02
PB0189 14 Tcfap2a_2 8,19E+00 1,36E+03
MA0067 8 Pax2 1,17E+01 1,95E+03
PB0010 14 Egr1_1 2,65E+01 4,39E+03
PB0127 17 Gata6_2 4,10E+01 6,81E+03
MA0079 10 SP1 4,38E+01 7,27E+03
doi:10.1371/journal.pone.0032394.t002
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test strategy used to calculate GO term overrepresentation is a
competitive test strategy [26]. It depends on the total number of
genes interrogated on the DNA chip, which include genes with
functions unrelated to those of the genes with a particular GO
term. Alternatively, a self-contained test strategy [26] that depends
only on the genes with a particular joined GO term may be
applied. Such a strategy is possible if an absolute value (e.g., a p-
value) is used to determine if a gene is differentially expressed.
The GOtree() function can be used in a self-contained test.
As an example, the GO terms overrepresented in genes with
increased expression in the serum-only samples compared with the
control samples can be calculated in a self-contained test. First,
genes with higher expression in serum-only samples are calculated
using the t.test function in R. The resulting p-values are
corrected for multiple tests by the false discovery rate method
using p.adjust [43] and the probe set IDs with corrected p-values
below the significance level subsequently stored in the variable
selfcontained.
Then GOtree() is used with the binomAlpha argument set (p-
value=0.05):
GOselfcontained ,- GOtree(selfcontained, binomAl-
pha=0.05)
Table 3 shows the results for the comparison between the
serum-only group and the controls. Mitosis and other terms
related to cell cycle progression were overrepresented. This result
is comparable to the GO analysis of the negative direction of the
1
st principal component (Fig. 2).
Parameter selection
As explained in the preceding sections the sign and the
magnitude of the loadings indicate the importance of a probe set
ID for a given principal component. Thus to join a functional
interpretation to a principal component the probe set IDs with the
highest absolute loadings with either positive og negative signs are
retrieved and analyzed for overrepresentation of GO terms in the
annotation or for overrepresentation of potential transcription
factor binding sites in the corresponding promoters. A facing issue
is the decision about at which magnitude of loading to set the cut-
off. For the serum stimulation example we have used the 2.5% of
the probe set ID variables with the highest absolute loadings in
both PC directions. The 2.5% cut-off was chosen here as it yielded
biological sound interpretations of gene expression data in
previous analysis (e.g. [12,14]). However, in other settings it may
be useful to be able to change the cut-off and to study the effect of
changing it.
Figure 4. The three most important PC1 and PC2 probes in both the positive and negative directions. The probes have been selected
by sorting the loadings from the PCA. The confidence intervals for the mean of each group (control, serumInhib and serumOnly) are plotted for each
probe set ID.
doi:10.1371/journal.pone.0032394.g004
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(cholesterol biosynthetic process) which was found overrepresented
in probe set IDs with the 2.5% highest loadings in PC2. Fig. 5
depicts the effect on the p-value of changing the fraction of probe
set IDs included from the 0.5% highest loadings to the 25%
highest loadings. It can be seen that the overrepresentation
(p,0.05) of this term is observed already when 0.5% of the probe
set IDs with the highest loadings are included and the
overrepresentation is maintained until 8.5% of the probe set IDs
with highest loadings are included. Further inclusion of probe set
IDs leads to p-values above 0.05. This is due to inclusion of probe
set IDs not annotated with the specific term in question. In fact
only 16 genes on the chip are annotated with this term
(GO:0006695) and 8 of these are found in the top 2.5% of probe
Set IDs with highest loadings. Clearly the number of probe set IDs
annotated with a given term will influence the outcome of the
parameter selection. We therefore now consider the term
GO:0043122 (‘‘regulation of I-kappaB kinase/NF-kappaB cas-
cade’’), which is annotated to 105 probe set IDs on the chip. This
term is overrepresented in the interval from 1.5% to 5.5%
included probe set IDs. For this term the changes of the p-values
are not monotone for increasing values of the cut-off (Figure 5).
This is due to groups of probe set IDs in the interval between 5.5%
to 25% that are annotated to this term having similar loadings
followed by groups of probe set IDs not annotated to this term.
The term GO:0007420 (‘‘Brain development’’) is annotated to
80 probe set IDs on the chip and was not found overrepresented in
the analysis. The calculated p-value for this term remained high
irrespective of the fraction of probe set IDs included (Fig. 5). In the
selection of probe set IDs for the overrepresentation analysis we
could have weighted the probe set IDs by the PCA-rank instead of
letting all included probe set IDs contribute equally to the test
statistics. However, the results depicted in Figure 5 suggest that
taking rank into account would only have minor effect. Thus both
significant terms remain significant over a relatively broad interval
of included probe set IDs. The main conclusion is that an interval
between 1.5% and 5% of included probe set IDs yields robust
results. Similar findings were found for the primo analysis.
Robustness under data perturbation
Cross-validation is a direct way to judge the robustness of the
PCA and the joined functional interpretations of the PC axes. This
can be achieved using the functions GOtreeWithLeaveOut and
primoWithLeaveOneOut. Thus, a fraction of experiments are left
out, and the PCA model builds using a data set with a reduced
number of experiments. This process is repeated until all samples
have been left out. The default is leave-one-out, but a fraction of
the samples to be left out can be given as an argument (e.g.,
leaveOut=0.1 results in the omission of 10% of the samples in
each run). For both functions, only GOterms (for GOtreeWith-
Table 3. Selfcontained test for overrepresentation (p,0.001) of GO terms in genes with higher expression in serum stimulated
cells compared to controls (FDR,0.05).
GOid Genes with term in list Total number of genes with term P-value GOterm
GO:0007049 69 481 1,18E-11 cell cycle
GO:0022403 44 237 5,37E-11 cell cycle phase
GO:0022402 54 360 5,12E-10 cell cycle process
GO:0000278 45 281 2,40E-09 mitotic cell cycle
GO:0000279 33 163 2,40E-09 M phase
GO:0000280 26 108 4,65E-09 nuclear division
GO:0007067 26 108 4,65E-09 mitosis
GO:0000087 26 111 6,61E-09 M phase of mitotic cell cycle
GO:0034984 37 212 6,61E-09 cellular response to DNA damage stimulus
GO:0048285 26 111 6,61E-09 organelle fission
GO:0006259 49 353 2,47E-08 DNA metabolic process
GO:0006974 37 230 6,08E-08 response to DNA damage stimulus
GO:0007059 16 51 2,60E-07 chromosome segregation
GO:0033554 45 333 2,60E-07 cellular response to stress
GO:0006260 28 153 3,28E-07 DNA replication
GO:0051726 33 205 3,81E-07 regulation of cell cycle
GO:0007346 22 103 7,31E-07 regulation of mitotic cell cycle
GO:0006281 29 173 1,15E-06 DNA repair
GO:0006297 9 17 3,09E-06 nucleotide-excision repair, DNA gap filling
GO:0000075 16 71 3,12E-05 cell cycle checkpoint
GO:0051716 49 460 6,37E-05 cellular response to stimulus
GO:0000070 9 27 3,25E-04 mitotic sister chromatid segregation
GO:0065004 11 42 3,81E-04 protein-DNA complex assembly
GO:0000819 9 28 4,19E-04 sister chromatid segregation
GO:0006323 13 61 5,93E-04 DNA packaging
GO:0051276 31 266 8,76E-04 chromosome organization
doi:10.1371/journal.pone.0032394.t003
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present in all runs are retrieved for subsequent ranking after p-
value. Thus, GO terms or PWMs that are only found in some of
the cross-validation runs are not present in the final list.
The command line:
GOtreePC2poscv ,- GOtreeWithLeaveOut(exprsData,
pc=2, decreasing=TRUE)
calculates overrepresented GO terms in the positive direction of
the 2
nd principal component using leave-one-out cross-validation.
The results (Table 4) show that GO terms related to sterol
metabolism were consistently overrepresented in the positive
direction of the 2
nd principal component.
Relationship to other annotation analysis strategies
Classically the biplot [44] is used in PCA and related
multivariate analysis methods for displaying the relationship
between variables and experiments in the same 2D-plot. Our
analysis strategy focuses, however, on the PC axes and is only
equivalent to a biplot analysis when the experiments are clearly
grouped and positioned close to the axes. The advantage of our
analysis strategy is that the axes can be interpreted in relation to
function and regulatory mechanisms even in the case where the
experiments are not clearly grouped in the plot. We believe that
our method of interpreting the axes is intuitive to biologists who
are not a priori experts in bioinformatics or biostatistics. Advanced
users interested in higher-level analysis of the link between
annotation and genome-wide gene expression data are referred
to [45,46,47,48].
The PcaGoPromoter analysis strategy relies on overrepresenta-
tion analysis. An alternative strategy would be to form an
aggregate score for a gene set defined by a GO term or a
transcription factor binding site. A very popular method
Figure 5. The Importance of loading cut-off for inclusion of probe set IDs in GO term annotation analysis. The probe set IDs were
sorted after loadings for the first principal component (GO:0043122 and GO:0007420) and second principal component (GO:0006695) following the
PCA of the serum stimulation data (Figure 2). Overrepresentation analysis for the three terms was repeated for different cut-off values between 0.5%
and 25% of probe set IDs with highest loadings. Shown are the resulting p-values. The vertical dotted line indicates the top 2.5% probe set IDs with
highest loadings. This is the cut-off used in the text and as the default in the pcaInfoPlot function. The horizontal dotted line indicates the 0.05
significance level.
doi:10.1371/journal.pone.0032394.g005
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(GSEA; [49]). One theoretical advantage of methods depending
on aggregate scores is that they only rely on the information
gathered from the genes included in the gene set. In the standard
use of pcaGopromoter, probe set IDs not annotated with a given
term contribute to the calculation of the p-value for overrepre-
sentation. To give the user the ability to calculate overrepresen-
tation which is only dependent on the probe set IDs annotated
with a given GO term, the GOtree function was supplemented
with the self-contained test option (see above).
Conclusions
The R package pcaGoPromoter provides a collection of tools for
the analysis of gene expression data obtained from any genome-wide
expression analysis platform supporting either of Affymetrix probe
set IDs, gene symbols or Entrez IDs as probe identifiers. It was
developed in the statistical environment R. The package pcaGo-
Promoter provides functionsto give an overview ofthe data byPCA,
functional interpretation by gene ontology terms (biological
processes), and an indication of the involvement of specific
transcription factors. In the present setup, a serum stimulation
experiment with a monocyte cell line was used for illustrative
purposes. In addition to the expected results, the pcaGoPromoter
analysis also revealed unexpected and interesting results when
applied to the serum stimulation data, e.g., an indication of
cholesterol synthesis in serum-starved cells and NF-kB activation
in cells treated with both serum and Erk1/2 map kinase inhibitor.
This directly demonstrates how the pcaGoPromoter package can be
used to direct attention towards relevant biological issues in various
genome-wide gene expression analyses in the future.
Web site access
A pcaGopromoter online version providing access to the most
important plot functions is available at http://gastro.sund.ku.dk/
brew/pcaGoPromoter.html .The serum stimulation experiment
used for calculations in this presentation is available as an
example. In addition the user can upload data for analysis. The
uploaded data should be either a zipped CEL file (with the
Affymetrix platform) or a csv table for other formats. The
extension R package can also be downloaded and installed locally.
Availability
Project name: pcaGoPromoter
Project home page: http://gastro.sund.ku.dk/brew/pcaGo
Promoter.html
Public repositories:
https://code.google.com/p/pcagopromoter/downloads/list
http://www.bioconductor.org/packages/2.10/bioc/html/pcaGo
Promoter.html
Table 4. Overrepresentation (p,0.05) of GO terms in the annotation of genes defining the positive direction of PC2 calculated
using leave-one-out cross-validation.
GOid p-value Total number of genes with term GOterm
GO:0008610 0,004 185 lipid biosynthetic process
GO:0002376 0,008 616 immune system process
GO:0008284 0,010 221 positive regulation of cell proliferation
GO:0045321 0,010 172 leukocyte activation
GO:0006629 0,011 480 lipid metabolic process
GO:0016126 0,013 14 sterol biosynthetic process
GO:0008202 0,013 117 steroid metabolic process
GO:0001775 0,017 199 cell activation
GO:0008652 0,017 15 cellular amino acid biosynthetic process
GO:0009309 0,019 31 amine biosynthetic process
GO:0042127 0,019 447 regulation of cell proliferation
GO:0019752 0,024 297 carboxylic acid metabolic process
GO:0006950 0,026 984 response to stress
GO:0006694 0,026 49 steroid biosynthetic process
GO:0006082 0,027 304 organic acid metabolic process
GO:0042180 0,027 304 cellular ketone metabolic process
GO:0006520 0,027 98 cellular amino acid metabolic process
GO:0048659 0,028 19 smooth muscle cell proliferation
GO:0033138 0,031 11 positive regulation of peptidyl-serine phosphorylation
GO:0016477 0,032 214 cell migration
GO:0006695 0,034 12 cholesterol biosynthetic process
GO:0008203 0,034 41 cholesterol metabolic process
GO:0006928 0,043 346 cellular component movement
GO:0030032 0,044 6 lamellipodium assembly
GO:0006066 0,047 212 alcohol metabolic process
GO:0048870 0,048 235 cell motility
doi:10.1371/journal.pone.0032394.t004
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Programming language: The R statistical environment
Other requirements: R version 2.10 or higher, Bioconduc-
tor 2.x
License: GNU GLP3
Any restrictions to use by non-academics: None
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